PRELUDE CAPITAL MANAGEMENT, LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 67 filers reported holding CTI BIOPHARMA CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2016$5,000
-44.4%
13,000
-47.8%
0.00%0.0%
Q3 2016$9,000
+350.0%
24,900
+329.3%
0.00%–
Q2 2016$2,000
-95.2%
5,800
-79.6%
0.00%
-100.0%
Q3 2015$42,000
-72.5%
28,500
-63.7%
0.01%
-71.4%
Q2 2015$153,000–78,500–0.02%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q2 2016.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders